Skip to content

Sunday, November 24, 2024

Latest:

Compassion beyond hospital curtains and prison bars
FROM THE LABS: From bench to bedside: Osteoarthritis gene therapy developed in the lab at Baylor is in clinical trials nationwide
The dangers of vaping
Thanksgiving nutrition: enjoying holiday favorites while staying on track with your health goals
How tau becomes a ‘bad guy’ that contributes to Alzheimer’s disease

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

vaccine development

Antibody response and ‘original antigenic sin’ in RSV influence vaccine development

February 11, 2021 COVID-19, immunity to RSV, Research, RSV, RSV antibodies, vaccine development

Variation of human immune response to RSV reinfection suggests it is important to consider this variation in vaccine design.

From the Labs: Image of the Month

From the Labs: Aging signs.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951